AI assistant
BIOLIFE SOLUTIONS INC — Director's Dealing 2020
Nov 27, 2020
32106_dirs_2020-11-27_b3dcc545-e31e-4123-bcca-45ad9835d493.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2020-11-24
Reporting Person: Casdin Partners Master Fund, L.P. (10% Owner)
Reporting Person: Casdin Capital, LLC (10% Owner)
Reporting Person: Casdin Partners GP, LLC (10% Owner)
Reporting Person: Casdin Eli (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-11-24 | Common Stock, par value $.001 per share | P | 1600000 | $22.50 | Acquired | 7440107 | Direct |
Footnotes
F1: The reported securities will be purchased by Casdin Partners Master Fund, L.P. (the "Master Fund") in a private transaction (the "Transaction"). As of November 24, 2020, all material conditions precedent to closing the Transaction have been satisfied.
F2: The securities are owned directly by the Master Fund and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC, the general partner of the Master Fund, and (ii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC.